ACTIVE SINCE: 2023-2026

Strengthening knowledge of health care workers and improving community awareness of colorectal and prostate cancer in Côte d’Ivoire, Cameroon and Rwanda

BIO Ventures for Global Health (BVGH), in collaboration with Amgen, will implement a structured program to improve frontline healthcare worker and general community awareness of colorectal and prostate cancer in Côte d'Ivoire, Cameroon and Rwanda.
Financial support Therapeutic area knowledge
Global NGOs 1

Africa’s cancer crisis is fueled by several complex and interrelated factors, including an inadequate number of frontline healthcare workers well-versed in the detection of cancers and the public’s limited awareness of cancer signs and when to seek care. Combined, these factors result in the late stage diagnoses common in Africa and their resulting poor outcomes.

Recognizing the importance of the early detection of colorectal and prostate cancer, BVGH will develop and implement customized training programs designed to fill gaps in frontline healthcare workers’ (and other specialist HCWs) colorectal and prostate cancer knowledge and skills. BVGH will also partner with local and international healthcare, advocacy, and communications experts to develop and deploy awareness campaigns, culturally appropriate education materials and treatment pathway maps for general audiences.

Geographic Reach
Disease Area
  • Non-communicable diseases
See Disease Areas
Partner organizations
Global NGOs
BIO Ventures for Global Health

BVGH will be responsible for all aspects related to the coordination, execution, monitoring, and evaluation of the training programs (noting that all training programs will be designed in partnership with local healthcare and government leaders to ensure that the programs align with local objectives, thus ensuring sustainability and regional ownership). BVGH will also work with country healthcare leaders and providers to develop reports describing Côte d'Ivoire’s, Cameroon’s, and Rwanda’s healthcare cancer treatment landscapes with respect to prostate and colorectal cancer care (and related) services.